|
1. BIOLOGIE
|
|
|
|
|
|
|
|
1.1 BIOLOGIE - GÉNOME
|
|
|
|
3.1.1 PRÉVENTION - TABAC - E-CIGS
|
|
|
|
|
|
|
|
4.9 DÉP., DIAG. & PRONO. - SEIN
|
|
|
|
5.12.5 IMMUNOTHÉRAPIES - PHARMA
|
|
|
|
5.12.5.1 IMMUNOTHÉRAPIES - BIOTECH
|
|
|
|
5.12.6 IMMUNOTHÉRAPIES - AMM
|
|
|
|
5.12.7 IMMUNOTHÉRAPIES - VACCINS
|
|
|
|
5.12.8 IMMUNOTHÉRAPIES - ECONOMIE
|
|
|
|
5.2.3 PHARMA - ÉCONOMIE
|
|
|
|
5.3 TRAITEMENTS - FDA, EMA, NICE...
|
|
|
|
5.3.4 TRAITEMENTS - AMM (FDA, EMA,...)
|
|
|
|
5.4 TRAITEMENTS - ECONOMIE
|
|
|
|
5.6 ESMO
|
|
|
Korea Drug Stock Soars After Plaudit But There Was No Award [Bloomberg]
|
|
|
|
|
|
HLB Inc., a South Korean drugmaker, almost doubled its stock price in the past two months after saying its gastric cancer treatment was named in “The Best of ESMO 2019” list by the European Society for Medical Oncology. But ESMO, a non-profit organization of medical professionals, said late Monday that there was never an official award. HLB had trumpeted its recognition from ESMO on Oct. 2.
|
|
|
|
|
|
|
6.3 ASSOCIATIONS/FONDATIONS
|
|
|
The Loneliest Cancer [Sarcoma UK]
|
|
|
|
|
|
The report gives a frank snapshot of what the current sarcoma landscape looks like in the UK, and reveals how sarcoma and a general lack of awareness around the cancer can have a devastating impact on both patients, their families and friends, from diagnosis through to treatment.
|
|
|
|
|
|
|
6.7 DMP, BIG DATA & APPLIS
|
|
|